ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 988,96
0,59%
Dow Jones
41 400,56
-0,08%
DAX
22 676,41
1,61%
Brent Oil
70,70
1,41%
Bitcoin
82 410,20
-0,55%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Elevation Oncology Inc (ELEV) Cours

Elevation Oncology Inc

Elevation Oncology Inc (ELEV)

NASDAQ
0,50775
0,01365
( 2,76% )
Mis à jour : 17:54:32
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
0,50775
Prix Achat
0,5015
Prix Vente
0,5104
Volume échangé
167 601
0,4901 Fourchette du Jour 0,518
0,4146 Plage de 52 semaines 5,8299
Cap du marché
30,018M
Clôture Veille
0,4941
Ouverture
0,50
Dernière Transaction
100
@
0.50775
Dernière heure de transaction
17:54:31
Volume financier
US$ 84 371
VWAP
0,503405
Volume moyen (3 m)
2 297 798
Actions en circulation
59 119 055
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,65
Bénéfice par action (BPA)
-0,77
Chiffre d'affairess
-
Bénéfice net
-45,7M

À propos de Elevation Oncology Inc

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be th... Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.elevationoncology.com
Siège social
Camden, Delaware, USA
Fondé
-
Elevation Oncology Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker ELEV. Le dernier cours de clôture d'Elevation Oncology était de US$0,49. Au cours de la dernière année, les actions de Elevation Oncology ont été négociées dans une fourchette de prix de US$ 0,4146 à US$ 5,8299.

Elevation Oncology compte actuellement 59 119 055 actions en circulation. La capitalisation boursière d'Elevation Oncology est de US$29,21 million. Elevation Oncology a un ratio cours/bénéfice (ratio PE) de -0.65.

ELEV Dernières nouvelles

Plus de nouvelles

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
06 Mars 2025
ELEV (2,76%)

Form 8-K - Current report
Edgar (US Regulatory)
06 Mars 2025
ELEV (2,76%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 Février 2025
ELEV (2,76%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 Février 2025
ELEV (2,76%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 Février 2025
ELEV (2,76%)

Form 8-K - Current report
Edgar (US Regulatory)
31 Janvier 2025
ELEV (2,76%)

Form 8-K - Current report
Edgar (US Regulatory)
13 Janvier 2025
ELEV (2,76%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.044659.641546102350.46310.53140.46136305900.49484165CS
4-0.10605-17.27761485830.61380.71890.414610200370.56900738CS
12-0.19075-27.30851825340.69850.980.414622977980.68416288CS
26-0.11585-18.5776138550.62360.980.414614272590.65984915CS
52-3.83225-88.30069124424.345.82990.414612102551.44486485CS
156-2.41225-82.61130136992.925.890.3639552422.23238152CS
260-13.49225-96.37321428571416.220.3637833992.33285378CS

ELEV - Frequently Asked Questions (FAQ)

What is the current Elevation Oncology share price?
The current share price of Elevation Oncology is US$ 0,50775
How many Elevation Oncology shares are in issue?
Elevation Oncology has 59 119 055 shares in issue
What is the market cap of Elevation Oncology?
The market capitalisation of Elevation Oncology is USD 29,21M
What is the 1 year trading range for Elevation Oncology share price?
Elevation Oncology has traded in the range of US$ 0,4146 to US$ 5,8299 during the past year
What is the PE ratio of Elevation Oncology?
The price to earnings ratio of Elevation Oncology is -0,65
What is the reporting currency for Elevation Oncology?
Elevation Oncology reports financial results in USD
What is the latest annual profit for Elevation Oncology?
The latest annual profit of Elevation Oncology is USD -45,7M
What is the registered address of Elevation Oncology?
The registered address for Elevation Oncology is 2140 S DUPONT HWY, KENT, CAMDEN, DELAWARE, 19934
What is the Elevation Oncology website address?
The website address for Elevation Oncology is www.elevationoncology.com
Which industry sector does Elevation Oncology operate in?
Elevation Oncology operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
CRVOCervoMed Inc
US$ 6,08
(157,63%)
106,6M
EHLDVEuroholdings Ltd
US$ 31,70
(79,10%)
32,92k
VSTEVast Renewable Ltd
US$ 0,768926
(53,82%)
166,13M
GRPNGroupon Inc
US$ 13,6891
(40,11%)
6,68M
ZENAZenaTech Inc
US$ 3,86
(37,37%)
1,2M
HITHealth In Tech Inc
US$ 1,25
(-83,24%)
4,24M
APDNApplied DNA Sciences Inc
US$ 0,05955
(-59,49%)
21,94M
ZYXIZynex Inc
US$ 3,2777
(-53,18%)
2,07M
HEPAHepion Pharmaceuticals Inc
US$ 0,05
(-40,48%)
48,11M
SMSISmith Micro Software Inc
US$ 0,6498
(-39,55%)
1,56M
STISolidion Technology Inc
US$ 0,1722
(36,56%)
498,35M
NVDANVIDIA Corporation
US$ 116,31
(6,94%)
201,04M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,21
(16,43%)
176,32M
VSTEVast Renewable Ltd
US$ 0,768926
(53,82%)
175,65M
CRVOCervoMed Inc
US$ 6,08
(157,63%)
111,49M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ELEV
Elevation Oncology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces